Company Overview of Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc., develops and commercializes drugs to treat metastatic cancer. The company focuses on developing CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Its products are used for the treatment of cancer and inflammatory diseases. The company was formerly known as Metastatix, Inc. Altiris Therapeutics, Inc. was founded in 2005 and is based in Atlanta, Georgia.
311 Ferst Drive, NW
Atlanta, GA 30332
Founded in 2005
Key Executives for Altiris Therapeutics, Inc.
Similar Private Companies By Industry
|Symmetry Corporation||United States|
|InKine Pharmaceutical Company, Inc.||United States|
|Invirion Diagnostics, LLC||United States|
|Nutritional Restart Pharmaceutical Limited Partnership||United States|
|Med-Pharmex, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Altiris Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.